West-Ward Recalls Fosphenytoin Sodium Injection Due to Particulate Matter
West-Ward Pharmaceutical Corp. is recalling specific lots of Fosphenytoin Sodium Injection because particles were found in stability and retain samples.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II. The hazard is the presence of particulate matter, which is a quality defect. No illnesses or injuries are reported in the source text, and the risk is not explicitly described as likely to cause serious health consequences, fitting the Moderate criteria for low-risk contamination or precautionary recalls.
Plain-English summary
West-Ward Pharmaceutical Corp. is recalling specific lots of Fosphenytoin Sodium Injection, USP, 500 mg PE per 10 mL. The product is packaged in 10 mL single-dose vials and is available under the labels NOVAPLUS and West-Ward. The recall involves 74,960 vials of the NOVAPLUS label and 911,070 vials of the West-Ward label.
The recall was initiated due to the discovery of particles in the stability samples and retain samples. The source text does not specify the nature of the particles or report any illnesses or injuries associated with the product. All affected lots were distributed throughout the US.
Consumers and healthcare providers should stop using the affected lots and contact West-Ward Pharmaceutical Corp. for further instructions. The specific lot numbers and expiration dates are listed in the recall documentation.
The recalled product
- Product
- FOSPHENYTOIN SODIUM (FOSPHENYTOIN SODIUM)
- Brand
- FOSPHENYTOIN SODIUM
- Manufacturer
- West-ward Pharmaceutical Corp.
- Category
- Drug — Injection
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #s: a) 112161.1
- 112162.1
- 112163.1
- Exp 05/13
- b) 102165.2
- 102167.1
- Exp 05/12
- 102190.1
- 102191.1
- 102191.2
- 102192.1
- 102213.1
- Exp 07/12
- 102240.1
- 102241.1
- 10227.1
- 102272.1
- 102272.2
- 102273.1
- 102274.1
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 2 recalled by West-ward Pharmaceutical Corp. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · FOSPHENYTOIN SODIUM
- ModerateWest-Ward Recalls Fosphenytoin Sodium Injection Due to Particulate Matter
FDA (Drugs) · 2012-08-08
Same manufacturer · West-ward Pharmaceutical Corp.
See all →- ModerateWest-Ward Recalls Fentanyl Citrate Injection Due to Impurity Failures
FDA (Drugs) · 2015-06-24
- ModerateWest-Ward Recalls Ethambutol Hydrochloride Tablets Due to Stability Failure
FDA (Drugs) · 2014-11-05
- ModerateWest-Ward Recalls Isoniazid Tablets Due to Dissolution Failure
FDA (Drugs) · 2014-07-09
- SevereWest-Ward Recalls Carisoprodol Tablets Due to Foreign Substance Presence
FDA (Drugs) · 2013-12-25
- SevereIrinotecan Hydrochloride Injection Recalled for Incorrect Formulation Calculation
FDA (Drugs) · 2013-11-13
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- CriticalAmerican Regent Recalls Papaverine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Nitroglycerin Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26